B ackground: Screening theoretically reduces death and morbidity from malignant melanoma. The rationale of screening for nonmelanoma skin cancer is more debat able, since mortality is very low.
ROGNOS1S OF m alignant
tions of melanomas, dysplastic nevi, and melanoma depends strongly other pigmented skin lesions and nonon early recognition. Screen-melanoma skin cancers, after a screening ing as a means of second-program with media attention focusing on ary prevention enhances melanoma only, early detection and, theoretically, re duces death and morbidity from mela----------noma.1,2 Visual examination of the skin by dermatologists is an acceptable, reliable, In Arnhem and Eindhoven in 1990, a toand inexpensive screening tool. Since tal of 2463 participants had been regis-1985, voluntary skin cancer and mela-tered. The campaign in Southern Limnoma screening clinics have been held in burg in 1993 attracted 4146 participants. the United States. 3 
'7 Similar clinics were
There was no marked difference in the sex organized in the Netherlands in 1989 (Oss) ratio between the 1990 and 1993 exerand in 1990 (Arnhem and Eindhoven).8 '10 cises. In Arnhem and Eindhoven, 47% of The screening exercises in the Nether-the screenees were younger than 50 years, lands were pilot studies to investigate the compared with 66% in Southern Limpractical implications of such screen-burg. The shift toward younger particiings. All screenings in the United States pants was highly significant (PC.001). and the Netherlands so far have concen-T a b le 1 summarizes the demographic trated on skin cancer in general, includ-profile of the attendees at both earn ing both melanoma and nonmelanoma paigns. skin cancer.
Mortality from nonmelanoma skin cancer is low. In terms of health strategy priorities, these skin lesions are insignifi cant. One may argue that skin cancer screening should be confined to malig nant melanoma. We studied the propor-
MATERIALS A N D METHODS
In June 1993, free melanoma detection clinics were conducted in Southern Limburg, the Netherlands, un der the auspices of the Dutch Academy of Dermatol ogy and Venereology and the Comprehensive Can cer Centers IKL (Maastricht, the Netherlands) and IKO (Nijmegen, the Netherlands). The area encom passes approximately 650 000 inhabitants. All der matologists in the region participated in the study. The screenees were examined at six hospital loca tions on a fii'st come, first served basis. The program was announced in the regional newspapers, on the regional radio and television stations, and by post ers in waiting rooms of general practitioners and in pharmacies and public libraries. Special emphasis was placed on the risk factors and symptoms of early ma lignant melanoma and its precursor lesions. No ref erence was made to the nonmelanoma skin cancers and their risk denominators.
Because of the large turnout, skin examina tions were confined to specific lesions the atten dants were worried about. Systematic examination of the entire skin was performed only on those who intentionally opted for a complete skin check and on those who showed a special skin mark that was sug gestive of dysplastic nevus or melanoma. These fac tors were the same ones used in the 1990 programs. When more than one clinical diagnosis was consid ered, only the single worst diagnosis was recorded. No biopsies or therapeutic interventions were per formed during the screenings.
The participant received a letter of referral with the proposed line of management to his or her fam ily physician when a cancerous or precancerous le sion was suspected. Persons with borderline lesions or minimal extent of precursor states were not re ferred so as to avoid undue concern and medical treat ment. Four months after the campaign, persons with a positive screen result were contacted for followup. Those who did not respond were approached again after 10 months.
The results of the Southern Limburg campaign were compared with those of two earlier campaigns in Arnhem in June 1990 and in Eindhoven in Octo ber 1990. The screenings in Arnhem and Eind hoven had been planned and executed in a similar way, biit die precampaign public releases had em phasized skin cancer in general instead of mela noma in particular. To test for differences between the two populations, the x 2 statistic was used. 
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í' y. (0.3%) . Six melanomas were diag nosed in Arnhem and 13 in Southern Limburg. Most melanomas diagnosed in Southern Limburg were early lesions: only one patient had a melanoma 1 mm thick or more. In Arnhem, tumor microstage was documented in five of six cases; three of these were 1 mm thick or more. This shift to thinner lesions was statistically significant (P=.04, Mann-Whitney test). The proportion of screenees with nonmelanoma skin cancer confirmed by patho logic examination was larger in Arnhem than in South ern Limburg (2.1% and 1.0%, respectively; P=.001). (common nevi, congenital nevi, dysplastic  nevi, and melanoma) , the odds ratios were statistically significantly increased in the Southern Limburg screen ing as compared with the Arnhem screening. The odds ratio for melanoma, including lentigo maligna, was 1.84 (95% confidence interval, 1.16 to 2.92). This study shows that when special emphasis is placed on the risk factors and symptoms of malignant melanoma and its precursor lesions in the public an nouncements and press releases, the percentages of screenees attending with skin lesions clinically sugges tive of common moles, congenital nevi, dvsülastic nevi. melanoma squamous carcinoma also applies to benign skin conditions, eg, eczema, pso riasis, dermatofibromas, and seborrheic keratoses.
Follow-up of the persons with presumed skin ma lignant neoplasms seen in 1990 was only achieved in the region of Arnhem, with 1961 participants; no follow-up data were available for the clinic held in Eindhoven, with 502 screenees. In 1993, follow-up was accomplished at all clinics in Southern Limburg. The proportion of mela nomas confirmed by pathologic examination was simi lar in both groups

T a b le 4 gives an overview of the malignant neoplasms confirmed by pathologic examination at follow-up. The difference in age distribution of both study popu lations prompted us to perform a logistic regression analy sis, including sex and age in the model. For all nevocellular lesions
We also compared the biopsy-proved skin malig nant neoplasms between both campaigns. Six melano mas were recorded in 1990: one lentigo maligna and five invasive melanomas. In the 1993 campaign, 13 melano mas were diagnosed: four lentigo maligna lesions, three in situ superficial spreading melanomas, five invasive mela nomas less than 1 mm thick, and only one thick mela noma (2.1 mm). Although the proportion of confirmed melanomas in both programs was similar (0.3%), the rela tive yield of early lesions was distinctly higher in the 1993 program (P=.04). The total number of confirmed mela nomas might have been higher in Southern Limburg if all suspected melanoma cases had been followed up. Fol low-up was incomplete for two possible melanomas and two cases of lentigo maligna. In Arnhem all presumptive ARCH DERMATOL/VOL 131, APR 1995 melanoma diagnoses were followed up. The total of 13 con firmed melanomas seems rather low. There were 72 po tential melanomas diagnosed, including 17 lentigo malig nas, in 69 persons. Sixty-eight tumors were adequately followed up. This gives a positive predictive value of only 19%. This low test performance probably results from the inclusion of many pigmented lesions with low clinical sus picion among the presumptive melanoma diagnoses.
The yield of histologically confirmed dysplastic nevi was 48. In Arnhem only 10 dysplastic nevi were histopathologically confirmed. Despite the incomplete follow-up of persons with presumed dysplastic nevi in both screening exercises, and the rather subjective interpre tation of diagnostic minutiae of dysplastic nevi by indi vidual dermatologists and histopathologists, we are con fident that the true rate of dysplastic nevi was substantially higher in the recent campaign.
The peak occurrence of cutaneous melanoma is at 40 to 50 years of age. Nonmelanoma skin cancer gener ally afflicts the elderly. Our 1990 campaigns exhibited a relative excess of elderly persons with peak attendance rates between 40 ancl 70 years. The 1993 series showed a preponderance of aclult screenees, with peak atten dance rates between 20 and 50 years. The shift toward a younger cohort is encouraging. In this respect, age is prob ably not a confounder. Nevertheless, we executed a mul tivariate analysis, which disclosed screening location to be an independent risk variable. In Southern Limburg, significantly more melanomas were clinically diag nosed than in Arnhem.
Attendees of skin cancer and melanoma screening programs differ from the general population in their risk profile.14 People attending in response to the multime dia publicity efforts seem to be at appropriately high risk. Screening exercises show a relatively high yield of con firmed skin cancers, as compared with the expected har vest of prevalent cases from the general population.3,6,7,0 On the other hand, the proper value of self-examination and self-selection as a screening tool has been ques tioned.15 To maximize the yield of screening, it is im perative to tailor programs to attract those persons at high est risk. Our survey demonstrates that precampaign messages must o n A most promising finding of our project is the de creased proportion of nonmelanoma skin cancers and cer tain precancerous states of low or negligible clinical and epidemiologic concern: basal and squamous cell carci nomas ' actinic keratoses. It is questioni screening procedures can alter the natural course of non melanoma skin cancer in a significant proportion of those screened. One of the major drawbacks of the rather ttn- 
